Asthma education and device training study using Foster Nexthaler
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether personalized education and training on using the Foster Nexthaler inhaler can help adults whose asthma is not well controlled despite current treatment. If you qualify, you will switch to Foster Nexthaler and receive tailored instruction on how to use it properly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your doctor has confirmed you have asthma that is not well controlled on your current treatment
- You have recently switched or will switch to the Foster Nexthaler inhaler (within a week of joining)
- You are able to perform a simple breathing test (spirometry)
- You do not have other serious lung or health conditions that could affect your asthma
- You have not used certain other asthma treatments like biologics or continuous oxygen
- You have not been in another clinical trial in the last 30 days or been hospitalized for asthma in the last 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combination inhaler (fluticasone propionate and albuterol) for people with asthma age 12 and older. It helps see if this inhaler works better than a placebo in controlling asthma symptoms and preventing attacks.
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
This study aims to improve how we diagnose and treat asthma in children. It tests whether a personalized approach can help children whose asthma is not well controlled with current inhaler treatments.
This trial tests whether stepping up to either a higher dose of inhaled steroid/long-acting bronchodilator or a special fine-particle triple therapy (which includes an extra medication) can improve small-airway health in people whose asthma is still not well controlled on a medium-dose combination.
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
This Phase 3 study tests whether an asthma care program with digital (phone-based) support helps people with severe asthma stay more stable and manage symptoms better. You may need to meet specific criteria for “severe, refractory” asthma and be willing to use a smartphone for monitoring and coaching.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.